{"id":"W4409374630","doi":"10.1016/j.jval.2025.03.010","title":"Cost-Effectiveness of Enfortumab Vedotin and Pembrolizumab for First-Line Metastatic Urothelial Cancer in the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Pembrolizumab; Urothelial cancer; Oncology; Medicine; Metastatic Urothelial Carcinoma; Internal medicine; Cancer; Urothelial carcinoma; Bladder cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00107433,0.0003154267,0.000853196,0.0005702497,0.0001713855,0.000863635,0.0003732079,0.0006380375,0.002190309],"category_scores_gemma":[0.00502942,0.0001675719,0.002148001,0.0006889944,0.0002574891,0.0007969721,0.0004453551,0.0009403913,0.00009202785],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003943148,"about_ca_system_score_gemma":0.001866083,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01952102,"about_ca_topic_score_gemma":0.02746126,"domain_scores_codex":[0.9990506,0.000509274,0.00007569385,0.00007236893,0.0001465975,0.0001454793],"domain_scores_gemma":[0.9986936,0.0005632174,0.0003374859,0.00002762591,0.00008409064,0.0002939035],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.1510379,0.004903355,0.2804686,0.003237241,0.01355311,0.0007503621,0.0002446835,0.0611144,0.002431832,0.00389153,0.01527271,0.4630943],"study_design_scores_gemma":[0.02292043,0.03125895,0.8437072,0.001945939,0.01762187,0.001466336,0.001309795,0.06345379,0.001664056,0.002912826,0.01159554,0.0001432322],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9689509,0.02298505,0.0001868426,0.002851958,0.0001450545,0.00009325019,0.001625377,0.00002023886,0.003141299],"genre_scores_gemma":[0.9970291,0.001924438,0.00009413411,0.0002788291,0.00002745938,0.00002090137,0.00038842,0.000001923571,0.0002348632],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01952102,"threshold_uncertainty_score":0.03881478,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0888941128100231,"score_gpt":0.4019829747432881,"score_spread":0.313088861933265,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}